JL
Insider
Jacob Steven Leach
President & COOJacob Steven Leach (President & COO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in DexCom, Inc. (DXCM). Across 1 priced purchase filing, the average 21-session return was +20.3% from execution and +20.3% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of DXCM (18,200 sh across 2 lots, as filed), executed Nov 10 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+20.3%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+20.3%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.0M
shares × price, as filed
Last traded
Nov 10 2025
Filed Nov 10 2025
Median ADV $483.2M across their filed names
Open performance→Volume by month
Buys $1.0M
Sells $1.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
DXCMRecent filings
DXCMPURCHASE
DexCom, Inc.
View filing →
$1.0M18,200 sh across 2 lots
Exec Nov 10 2025
Filed Nov 10 2025 · 7:13 PM ET DXCMSALE DexCom, Inc. View filing → $991K
14,076 sh × $70.38
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. View filing → $229K
2,634 sh × $86.91
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET